Investors Purchase Large Volume of Cypherpunk Technologies Call Options (NASDAQ:CYPH)

Cypherpunk Technologies (NASDAQ:CYPH) was the target of unusually large options trading activity on Wednesday. Traders bought 4,594 call options on the stock. This represents an increase of 89% compared to the typical volume of 2,430 call options.

Insider Buying and Selling at Cypherpunk Technologies

In related news, Director Thomas Dietz sold 20,000 shares of the company’s stock in a transaction on Wednesday, August 26th. The stock was sold at an average price of $1.72, for a total value of $34,400.00. Following the transaction, the director directly owned 132,500 shares of the company’s stock, valued at $227,900. This represents a 13.11% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 3.50% of the stock is owned by company insiders.

Hedge Funds Weigh In On Cypherpunk Technologies

Hedge funds and other institutional investors have recently bought and sold shares of the company. Millennium Management LLC purchased a new stake in shares of Cypherpunk Technologies in the 4th quarter worth about $37,000. LPL Financial LLC acquired a new position in shares of Cypherpunk Technologies during the 4th quarter worth approximately $38,000. Caitong International Asset Management Co. Ltd purchased a new stake in Cypherpunk Technologies in the 4th quarter valued at approximately $44,000. Sequoia Financial Advisors LLC purchased a new stake in Cypherpunk Technologies in the 4th quarter valued at approximately $56,000. Finally, HighTower Advisors LLC acquired a new stake in Cypherpunk Technologies during the 4th quarter valued at $59,000. 30.46% of the stock is currently owned by hedge funds and other institutional investors.

Cypherpunk Technologies Trading Up 15.2%

Cypherpunk Technologies stock traded up $0.40 during trading on Wednesday, hitting $3.03. The company had a trading volume of 10,077,202 shares, compared to its average volume of 4,130,036. The stock has a market cap of $326.51 million, a price-to-earnings ratio of 5.41 and a beta of 0.33. Cypherpunk Technologies has a 1-year low of $0.28 and a 1-year high of $3.70. The company’s 50 day simple moving average is $1.02 and its 200-day simple moving average is $0.90.

Cypherpunk Technologies (NASDAQ:CYPH) last released its quarterly earnings results on Wednesday, August 12th. The company reported $0.18 EPS for the quarter.

Analyst Upgrades and Downgrades

CYPH has been the subject of a number of research reports. Weiss Ratings raised Cypherpunk Technologies from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Monday, August 17th. Wall Street Zen raised Cypherpunk Technologies from a “sell” rating to a “hold” rating in a report on Saturday, July 4th. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $1.60 price objective on shares of Cypherpunk Technologies in a research note on Thursday, August 27th. One research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $1.60.

Cypherpunk Technologies Company Profile

Cypherpunk Technologies Inc, previously known as Leap Therapeutics, Inc, is a company developing novel therapies for patients with cancer and implementing a digital asset treasury strategy focused on Zcash. The company’s research platform centers on modulating the tumor microenvironment to enhance anti-tumor immune responses. Cypherpunk’s proprietary pipeline includes DKN-01, a monoclonal antibody designed to neutralize Dickkopf-1 (DKK1), a protein implicated in tumor growth and immune evasion.

DKN-01 is being evaluated both as a monotherapy and in combination with checkpoint inhibitors such as pembrolizumab across multiple solid tumor indications, including gastroesophageal, pancreatic and other advanced malignancies.